Diabetes medication appears to slow progress of Parkinson’s disease in French-backed trial

A Type 2 diabetes medication called lixisenatide appeared to slow the progression of Parkinson’s disease symptoms in a small, mid-stage trial funded by the French Ministry of Health.

Previous post ‘I have been propping her up for 15 years’: My niece, 35, is horrible with money. How can I help her become financially responsible?
Next post 5 top cities for retirees who want to work part time